These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 37883238)

  • 21. A primer on nerve agents: what the emergency responder, anesthesiologist, and intensivist needs to know.
    Candiotti K
    Can J Anaesth; 2017 Oct; 64(10):1059-1070. PubMed ID: 28766156
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro comparison of the acetylcholinesterase inhibition caused by V- and A-series nerve agents' surrogates.
    Kitagawa DAS; Dos Santos MC; Kuča K; França TCC; Cavalcante SFA
    Chem Biol Interact; 2023 Sep; 383():110678. PubMed ID: 37595776
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human butyrylcholinesterase efficacy against nerve agent exposure.
    Reed BA; Sabourin CL; Lenz DE
    J Biochem Mol Toxicol; 2017 May; 31(5):. PubMed ID: 28225154
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of Different Hair and Skin Decontamination Strategies with Identification of Associated Hazards to First Responders.
    Larner J; Durrant A; Hughes P; Mahalingam D; Rivers S; Matar H; Thomas E; Barrett M; Pinhal A; Amer N; Hall C; Jackson T; Catalani V; Chilcott RP
    Prehosp Emerg Care; 2020; 24(3):355-368. PubMed ID: 31251095
    [No Abstract]   [Full Text] [Related]  

  • 25. Volunteer trials of a novel improvised dry decontamination protocol for use during mass casualty incidents as part of the UK'S Initial Operational Response (IOR).
    Amlôt R; Carter H; Riddle L; Larner J; Chilcott RP
    PLoS One; 2017; 12(6):e0179309. PubMed ID: 28622352
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Decontamination of organophosphorus compounds: Towards new alternatives].
    Poirier L; Jacquet P; Elias M; Daudé D; Chabrière E
    Ann Pharm Fr; 2017 May; 75(3):209-226. PubMed ID: 28267954
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Environmental exposure to organophosphorus nerve agents.
    Vucinic S; Antonijevic B; Tsatsakis AM; Vassilopoulou L; Docea AO; Nosyrev AE; Izotov BN; Thiermann H; Drakoulis N; Brkic D
    Environ Toxicol Pharmacol; 2017 Dec; 56():163-171. PubMed ID: 28942081
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [On necessity to modify biochemical methods for detecting organophosphorus componds in chemical weapons extinction objects (review of literature)].
    Prokofieva DS; Shmurak VI; Sadovnikov SV; Gontcharov NV
    Med Tr Prom Ekol; 2015; (3):42-6. PubMed ID: 26036024
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Organic-Molecule-Based Fluorescent Chemosensor for Nerve Agents and Organophosphorus Pesticides.
    Gori M; Thakur A; Sharma A; Flora SJS
    Top Curr Chem (Cham); 2021 Aug; 379(5):33. PubMed ID: 34346011
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novichoks: The Dangerous Fourth Generation of Chemical Weapons.
    Franca TCC; Kitagawa DAS; Cavalcante SFA; da Silva JAV; Nepovimova E; Kuca K
    Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30862059
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novichoks - The A group of organophosphorus chemical warfare agents.
    Kloske M; Witkiewicz Z
    Chemosphere; 2019 Apr; 221():672-682. PubMed ID: 30677728
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of skin decontamination strategies in the initial operational response following chemical exposures.
    Thors L; Wigenstam E; Qvarnström J; Larsson A; Lindberg S; Öberg L; Rattfelt-Nyholm J; Bucht A
    Toxicol In Vitro; 2023 Mar; 87():105539. PubMed ID: 36539105
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reactive skin decontamination lotion (RSDL) for the decontamination of chemical warfare agent (CWA) dermal exposure.
    Schwartz MD; Hurst CG; Kirk MA; Reedy SJ; Braue EH
    Curr Pharm Biotechnol; 2012 Aug; 13(10):1971-9. PubMed ID: 22352732
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chemical warfare agents: II. Nerve agents.
    Sidell FR; Borak J
    Ann Emerg Med; 1992 Jul; 21(7):865-71. PubMed ID: 1610046
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Organophosphorus nerve agent poisoning: managing the poisoned patient.
    Hulse EJ; Haslam JD; Emmett SR; Woolley T
    Br J Anaesth; 2019 Oct; 123(4):457-463. PubMed ID: 31248646
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Strategies for developing a recombinant butyrylcholinesterase medical countermeasure for Organophosphorus poisoning.
    Allard JL; Shields KA; Munro TP; Lua LHL
    Chem Biol Interact; 2022 Aug; 363():109996. PubMed ID: 35654125
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro human skin decontamination efficacy of MOF-808 in decontamination lotion following exposure to the nerve agent VX.
    Larsson A; Qvarnström J; Lindberg S; Wigenstam E; Öberg L; Afshin Sander R; Johansson S; Bucht A; Thors L
    Toxicol Lett; 2021 Mar; 339():32-38. PubMed ID: 33370593
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anticonvulsant discovery through animal models of status epilepticus induced by organophosphorus nerve agents and pesticides.
    McCarren HS; McDonough JH
    Ann N Y Acad Sci; 2016 Jun; 1374(1):144-50. PubMed ID: 27258770
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Blaptica dubia as sentinels for exposure to chemical warfare agents - a pilot study.
    Worek F; Seeger T; Neumaier K; Wille T; Thiermann H
    Toxicol Lett; 2016 Nov; 262():12-16. PubMed ID: 27639501
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.